D. Vervloet

J. Bousquet, I. Annesi-Maesano, M. Lathrop, 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Allergic vs nonallergic asthma: what makes the difference?

A. Magnan, D. Charpin, D. Vervloet, 2002, Allergy.

The Drug Ambassador Project - The diversity of diagnostic procedures for drug allergy around Europe

P. Demoly, M. Kowalski, J. Ring, 2005 .

Increased prevalence of asthma and allied diseases among active adolescent tobacco smokers after controlling for passive smoking exposure. A cause for concern?

I. Annesi-Maesano, C. Raherison, C. Kopferschmitt, 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Drugs that may injure the respiratory system.

J. Vergnon, P. Godard, P. Pfitzenmeyer, 1997, The European respiratory journal.

Assessment of a therapeutic education programme for asthma patients: "un souffle nouveau".

C. Marchand, J. D'ivernois, H. Méchin, 2005, Patient education and counseling.

[2000 classification of idiopathic interstitial lung diseases].

B. Chetaille, F. Retornaz, M. Reynaud‐Gaubert, 2004, La Revue de medecine interne.

Bird Fancier’s Disease Incidentally Diagnosed by Thallium Scanning: A Case Report

J. Serratrice, P. Disdier, P. Weiller, 2000, Respiration.

Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients. Marseille and Montréal Lung Transplantation Group.

L. Garbe, B. Méric, J. Mege, 1996, American journal of respiratory and critical care medicine.

Twenty five year mortality and air pollution: results from the French PAARC survey

F Kauffmann, P Brochard, C Declercq, 2005, Occupational and Environmental Medicine.

Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics

B. Bruguerolle, D. Vervloet, M. Toumi, 2007, European Journal of Clinical Pharmacology.

Histamine induces Th2 activation through the histamine receptor 1 in house dust mite rhinitic but not asthmatic patients

A. Magnan, K. Botturi, Y. Lacoeuille, 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Diesel exhaust particles enhance T‐cell activation in severe asthmatics

A. Magnan, D. Vervloet, E. Mamessier, 2006, Allergy.

Absolute Determination of IgE Antibodies to Grass Pollen Allergens

J. Charpin, P. Bongrand, D. Vervloet, 1978, Allergy.

The inhibitory effect of serum factors on measurement of IgE aspergillus antibodies by RAST

D. Vervloet, R. Reisman, C. Arbesman, 1974 .

EVOLUTION OF REAGINIC ANTIBODIES IN SPECIFIC HYPOSENSITIZATION

J. Charpin, D. Vervloet, J. Aubert, 1974, Acta allergologica.

Induction of late cutaneous reaction by kallikrein injection: comparison with allergic-like late response to compound 48/80.

J. Charpin, M. Sapéne, J. Bonerandi, 1983, The Journal of allergy and clinical immunology.

Prostaglandins and asthma: The use of blood components for metabolic studies.

D. Vervloet, C. Arbesman, A. Attallah, 1976, The Journal of allergy and clinical immunology.

Single, high dose intramuscular triamcinolone acetonide versus weekly oral methotrexate in life-threatening asthma: a double blind study.

D. Charpin, D. Vervloet, 1996, American journal of respiratory and critical care medicine.

Assessment of T lymphocyte cytokine production in induced sputum from asthmatics: a flow cytometry study

P. Bongrand, S. Boniface, A. Magnan, 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Alveolar macrophage interleukin (IL)‐10 and IL‐12 production in atopic asthma

P. Bongrand, A. Magnan, D. Vervloet, 1998, Allergy.

[Environmental factors for asthma severity and allergy: results from the EGEA study].

J. Bousquet, V. Siroux, I. Pin, 2007, Revue des maladies respiratoires.

Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma.

P. Bongrand, L. Mély, A. Magnan, 2000, American journal of respiratory and critical care medicine.

Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.

A. Magnan, K. Botturi, D. Vervloet, 2009, Respiratory medicine.

Prevalence of self-reported respiratory symptoms in workers exposed to isocyanates.

D. Charpin, D. Vervloet, I. Sari-Minodier, 1999, Journal of occupational and environmental medicine.

Seasonal allergic symptoms and their relation to pollen exposure in south‐east France

D. Charpin, D. Vervloet, J. Sutra, 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Reliability of respiratory symptoms to diagnose atopy

D. Charpin, D. Vervloet, A. Lanteaume, 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Atopy and systemic reactions to drugs

D. Charpin, D. Vervloet, J. Kleisbauer, 1990, Allergy. European Journal of Allergy and Clinical Immunology.

Sex‐difference in reporting allergic symptoms

D. Charpin, D. Vervloet, J. Kleisbauer, 1988, Clinical allergy.

Anaphylactic reactions to modified fluid gelatins.

J. Charpin, M. Senft, D. Vervloet, 1983, The Journal of allergy and clinical immunology.

[Economic burden of COPD: the SCOPE study].

I. Durand-zaleski, B. Housset, P. Godard, 2005, Revue des maladies respiratoires.

Unequal day-night terbutaline i.v. dosing in acute severe asthma: effect on nocturnal bronchial patency, heart rate, and arterial pressure.

B. Bruguerolle, F. Lagier, D. Vervloet, 1991, Chronobiology international.

Study of cytokine gene expression in small cell samples: use in induced sputum.

M. Reynaud‐Gaubert, S. Boniface, A. Magnan, 2003, Journal of immunological methods.

Fel d 1 production in the cat skin varies according to anatomical sites

A. Magnan, D. Vervloet, N. Carayol, 2000, Allergy.

Cat sex differences in major allergen production (Fel d 1).

D. Charpin, D. Vervloet, J. Birnbaum, 1998, The Journal of allergy and clinical immunology.

Fel d I levels in cat anal glands

D. Charpin, D. Vervloet, J. Birnbaum, 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Cockroaches and mites share the same beds.

D. Charpin, D. Vervloet, J. Birnbaum, 1995, The Journal of allergy and clinical immunology.

Indoor allergen levels in day nurseries.

D. Charpin, D. Vervloet, J. Birnbaum, 1995, The Journal of allergy and clinical immunology.

Effects of castration and testosterone on Fel d I production by sebaceous glands of male cats: I—immunological assessment

P. Berbis, D. Vervloet, D. Charpin, 1994 .

Effects of castration and testosterone on Fel dI production by sebaceous glands of male cats: II--Morphometric assessment.

D. Charpin, D. Vervloet, C. Charpin, 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Cat removal and Fel d I levels in mattresses.

D. Charpin, D. Vervloet, E. Haddi, 1991, The Journal of allergy and clinical immunology.

Withdrawal of the Medihalerepi®/Adrenaline Medihaler®: comments of the Subcommittee on Insect Venom Allergy of the EAACI

H. Mosbech, B. Przybilla, D. Vervloet, 1998, Allergy.

EAACI Position paper + : Adrenaline for emergency kits

W. Aberer, H. Mosbech, B. Przybilla, 1995 .

Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols

D. Charpin, D. Vervloet, J. Birnbaum, 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Prevalence of allergy to Hymenoptera stings.

J. Charpin, D. Charpin, D. Vervloet, 1990, Allergy proceedings : the official journal of regional and state allergy societies.

Allergy to sunflower honey associated with allergy to celery

J. Charpin, D. Charpin, D. Vervloet, 1989, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Phenotypic determinants of uncontrolled asthma.

J. Bousquet, V. Siroux, J. Cracowski, 2009, The Journal of allergy and clinical immunology.

Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers.

D. Vervloet, C. André, D. Herman, 2000, The Journal of allergy and clinical immunology.

Triggers in Intrinsic Asthma in the EGEA Study

D. Charpin, D. Vervloet, A. Lanteaume, 2003, The Journal of asthma : official journal of the Association for the Care of Asthma.

Variation of T‐cell activation in allergic subjects during natural pollen exposure

A. Magnan, D. Vervloet, F. Milhe, 2005, Allergy.

T cell activation, from atopy to asthma: more a paradox than a paradigm

S. Boniface, A. Magnan, D. Vervloet, 2003, Allergy.

Sex difference in Fel d 1 allergen production.

J. Mege, D. Charpin, D. Vervloet, 1996, The Journal of allergy and clinical immunology.

Epidemiology of hymenoptera allergy

D. Charpin, D. Vervloet, J. Birnbaum, 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Effect of dry cleaning on mite allergen levels in blankets

D. Charpin, D. Vervloet, J. Birnbaum, 1993, Allergy.

Fel d I allergen: skin and or saliva?

D. Charpin, D. Vervloet, C. Charpin, 1992, Annals of allergy.

Fel d I allergen distribution in cat fur and skin.

D. Charpin, D. Vervloet, C. Charpin, 1991, The Journal of allergy and clinical immunology.

Comparison of the ACAREX test with monoclonal antibodies for the quantification of mite allergens.

D. Charpin, A. Michel-Nguyen, D. Vervloet, 1991, The Journal of allergy and clinical immunology.

Phenotypes of asthma revisited upon the presence of atopy.

P. Godard, S. Boniface, A. Magnan, 2005, Respiratory medicine.

Intranasal Fluticasone Once Daily Compared with Once-Daily Cetirizine in the Treatment of Seasonal Allergic Rhinitis

D. Charpin, D. Vervloet, J. Desfougères, 1997, Clinical drug investigation.

Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4

A. Magnan, K. Botturi, Y. Lacoeuille, 2011, Respiratory research.

[Epidemiological study of genetic and environmental factors in asthma, bronchial hyperresponsiveness and atopy. Protocol and potential selection bias].

J. Bousquet, I. Annesi-Maesano, M. Lathrop, 2001, Revue d'epidemiologie et de sante publique.

Dog factor differences in Can f 1 allergen production

A. Magnan, D. Vervloet, M. El Biaze, 2005, Allergy.

Simpler is not always better.

D. Charpin, D. Vervloet, 1994, Chest.

[The need for and limits of diagnostic tests for professional asthma].

G. Pauli, D. Vervloet, J. Bessot, 2002, Revue des maladies respiratoires.

Safety and Efficacy of Juniperus ashei Sublingual-Swallow Ultra-Rush Pollen Immunotherapy in Cypress Rhinoconjunctivitis

D. Vervloet, C. André, J. Birnbaum, 2006, International Archives of Allergy and Immunology.

Oral and sublingual immunotherapy

D. Vervloet, 1998 .

Role of the quaternary ammonium ion determinants in allergy to muscle relaxants.

J. Charpin, P. Bongrand, M. Senft, 1987, The Journal of allergy and clinical immunology.

What is an Allergist? Reconciled Document Incorporating Member Society Comments, September 3, 2007

E. Valovirta, M. Kaliner, Liu Guanghui, 2008, The World Allergy Organization Journal.

Relationship between skin reactions to common allergens and non‐specific bronchial reactivity in young healthy subjects

J. Charpin, M. Badier, F. Lagier, 1987, Clinical allergy.

Process intensification of tubular reactors: Considerations on catalyst hold-up of structured packings

Freek Kapteijn, John Nijenhuis, J. Ruud van Ommen, 2013 .

Selectivity of the Fischer–Tropsch process: deviations from single alpha product distribution explained by gradients in process conditions

F. Kapteijn, J. R. Ommen, D. Vervloet, 2013 .

Intensifying The Fischer-Tropsch Synthesis By Reactor Structuring - A Model Study

Robert F. Mudde, Freek Kapteijn, J. R. van Ommen, 2012 .

ALLERGIE AU LATEX

D. Vervloet, J. Birnbaum, 1998 .

Sensitization to aluminium by aluminium‐precipitated dust and pollen extracts

L. Garbe, B. Mallet, D. Vervloet, 1988, Contact dermatitis.

Ultra‐rush venom immunotherapy induces differential T cell activation and regulatory patterns according to the severity of allergy

A. Magnan, D. Vervloet, E. Mamessier, 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

518 Prevalence of latex allergy in nurses working in operating rooms

F. Lagier, D. Charpin, D. Vervloet, 1991 .

Occupational asthma in France: a 1-yr report of the Observatoire National de Asthmes Professionnels project

M. Kopferschmitt‐Kubler, G. Pauli, D. Vervloet, 2002, European Respiratory Journal.

Cyclic AMP in Hypersensitivity Reactions

D. Vervloet, F. Anfosso, J. Charpin, 1979, Allergy.

Histamine release from human leukocytes: modulation by cadmium ion.

D. Vervloet, R. Reisman, C. Arbesman, 1975, The Journal of allergy and clinical immunology.

Immunotherapy in allergic respiratory diseases

D. Charpin, D. Vervloet, J. Birnbaum, 2007, Lung.

Diagnosis of drug allergic reactions

D. Charpin, D. Vervloet, F. Porri, 1995, Clinical reviews in allergy & immunology.

Effect of 17q21 variants and smoking exposure in early-onset asthma.

J. Bousquet, M. Lathrop, D. Zélénika, 2008, The New England journal of medicine.

Adverse reactions to suxamethonium and other muscle relaxants under general anestesia

J. Charpin, M. Senft, D. Vervloet, 1983 .

Effects of castration and testosterone on Fel dI production by sebaceous glands of male cats: I--Immunological assessment.

P. Berbis, D. Charpin, D. Vervloet, 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Cat skin as an important source of Fel d I allergen.

D. Charpin, D. Vervloet, M. Soler, 1990, The Journal of allergy and clinical immunology.

Basophiles et mastocytes

J. Charpin, D. Vervloet, Jacques Charpin, 1980 .

Adverse Reactions Due to Muscle Relaxants

J. Charpin, D. Vervloet, E. Nizankovska, 1983 .

Leukocyte histamine release to suxamethonium in patients with adverse reactions to muscle relaxants.

J. Charpin, P. Bongrand, M. Senft, 1985, Journal of Allergy and Clinical Immunology.

Anaphylactic reactions to muscle relaxants under general anesthesia.

J. Charpin, D. Vervloet, A. Arnaud, 1979, The Journal of allergy and clinical immunology.

Analysis of cell structural and functional diversity by combination of micromanipulation and microfluorimetry

P. Bongrand, A. Benoliel, C. Capo, 1987, Cell Biophysics.

An incidental finding in a 34-year-old male under investigation for haemoptysis

J. Gaubert, D. Vervloet, D. Pinot, 2009, European Respiratory Journal.

Hymenoptera ultra‐rush venom immunotherapy (210 min): a safety study and risk factors

A. Magnan, D. Vervloet, J. Birnbaum, 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Risk factors for allergic or pseudoallergic reactions in the perioperative period

D. Charpin, D. Vervloet, Michel Pradal, 1991, Clinical reviews in allergy.

Oxygenation improvement with almitrine bismesylate in the hepatopulmonary syndrome

M. Reynaud‐Gaubert, A. Magnan, D. Vervloet, 2006 .

Heat Transfer Properties of Structured Packings for Biofuel Production via Fischer-Tropsch Synthesis

J. Nijenhuis, F. Kapteijn, D. Vervloet, 2008 .

Relationships between natural T cells, atopy, IgE levels, and IL‐4 production

A. Necker, B. Malissen, P. Bongrand, 2000, Allergy.

Cytokines, from atopy to asthma: the Th2 dogma revisited.

S. Boniface, L. Mély, A. Magnan, 2001, Cellular and molecular biology.

Sex difference in asthma prevalence

D. Charpin, D. Vervloet, A. Lanteaume, 1997, Allergy.

Aggressive form of pleural epithelioid haemangioendothelioma: complete response after chemotherapy.

L. Garbe, A. Magnan, D. Vervloet, 1999, The European respiratory journal.

Latex allergy: allergen identification in Hevea braziliensis fractions by immunoblotting

J. Mege, C. Capo, J. Jacob, 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

A prospective national study of the safety of immunotherapy

J. Charpin, D. Vervloet, E. Khairallah, 1980, Clinical allergy.

Aspirin intolerance and asthmal induction of a tolerance and long‐term monitoring

D. Vervloet, P. Dor, G. Baldocchi, 1985, Clinical allergy.

Prevalence of latex sensitization in subjects attending health screening: implications for a perioperative screening

C. Lemière, D. Charpin, D. Vervloet, 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Allergy to muscle relaxants and related compounds

D. Vervloet, 1985, Clinical allergy.

Allergy during anaesthesia

D. Charpin, D. Vervloet, J. Birnbaum, 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Association between Latex Sensitization and Repeated Latex Exposure in Children

C. Lemière, J. Mege, D. Charpin, 1997, Anesthesiology.

Dust mite allergens and asthma: report of a second international workshop.

W. Thomas, T. Platts-Mills, R. Aalberse, 1992, The Journal of allergy and clinical immunology.

Indoor allergens and asthma: report of the Third International Workshop.

W. Thomas, M. Chapman, T. Platts-Mills, 1997, The Journal of allergy and clinical immunology.

Latex as aeroallergen

M. Badier, F. Lagier, D. Charpin, 1990, The Lancet.

Prevalence of latex allergy in operating room nurses.

F. Lagier, D. Charpin, D. Vervloet, 1992, The Journal of allergy and clinical immunology.

[AIDS: a model for the study of atopy?].

A. Magnan, D. Vervloet, 1995, Revue des maladies respiratoires.

Value of ELISA using A60 antigen in the diagnosis of active pulmonary tuberculosis.

P. de Micco, J. Charpin, D. Charpin, 1990, The American review of respiratory disease.

[Suspicion on sulfites].

J. Charpin, D. Vervloet, E. Giffon, 1989, Revue des maladies respiratoires.

Allergy to latex

D. Vervloet, D. Charpin, F. Leynadier, 1992, Allergy.

Adrenaline for emergency kits.

W. Aberer, H. Mosbech, B. Przybilla, 1995, Allergy.

Allergic emergencies seen in surgical suites

A. Magnan, D. Vervloet, J. Birnbaum, 1999, Clinical reviews in allergy & immunology.

Is systematic preoperative screening for muscle relaxant and latex allergy advisable?

D. Charpin, D. Vervloet, F. Gouin, 1995, Allergy.

Allergy to suxamethonium: persisting abnormalities in skin tests, specific IgE antibodies and leucocyte histamine release

J. Charpin, M. Senft, F. Lagier, 1987, Clinical allergy.

The French Experience of Anaphylactoid Reactions

D. Moneret-vautrin, D. Vervloet, 1985, International anesthesiology clinics.

Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening

C. Lemière, D. Charpin, D. Vervloet, 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Allergy to muscle relaxants

D. Vervloet, J. Birnbaum, 1991, Clinical reviews in allergy.

Limits of interpretation of screening tests for anaphylactic shock to muscle relaxants.

D. Charpin, D. Vervloet, J. Birnbaum, 1993, Annales francaises d'anesthesie et de reanimation.

Anaphylactic reactions to suxamethonium prevention of mediator release by choline.

J. Charpin, P. Bongrand, M. Senft, 1985, The Journal of allergy and clinical immunology.

Adverse reactions to suxamethonium and other muscle relaxants under general anesthesia.

J. Charpin, M. Senft, D. Vervloet, 1984, The Journal of allergy and clinical immunology.

Cross‐sensitivity between relaxants

D. Moneret-vautrin, D. Galletly, M. Fisher, 1986 .

[Anaphylactic shock in general anesthesia: apropos of 41 acute accidents caused by myorelaxants].

J. Charpin, D. Vervloet, 1983, Bulletin de l'Académie Nationale de Médecine.

Epidemiology of Immediate-Type Allergic Reactions to Latex

D. Charpin, D. Vervloet, 1993, Clinical reviews in allergy.

Atopy and anaphylactic reactions to suxamethonium.

J. Charpin, M. Senft, Y. Hémon, 1988, The Journal of allergy and clinical immunology.

[Allergy to muscle relaxants in general anesthesia].

D. Vervloet, 1989, Presse medicale.

Tests cutanés aux myorelaxants.

D. Vervloet, 1988 .

ANAPHYLACTOID REACTIONS TO SUXAMETHONIUM

D. Vervloet, 1983, The Lancet.

RevueAccidents anaphylactoïdes graves peranesthésiquesLife-threatening anaphylactoid reactions during general anaesthesia

D. Moneret-vautrin, G. François, D. Vervloet, 1985 .

Epidemiology of Various Allergic Reactions

D. Charpin, D. Vervloet, 1991 .

Sublingual‐swallow immunotherapy (SLIT) in patients with asthma due to house‐dust mites: a double‐blind, placebo‐controlled study

D. Caillaud, J. Bousquet, A. Tonnel, 1999, Allergy.

Mechanisms of anaphylactic reactions to muscle relaxants: role of allergenic determinants.

D. Vervloet, J. Birnbaum, 1992, Monographs in allergy.

Patch test reactions to mite antigens: a GERDA* multicentre study

A. Taieb, J. Lachapelle, D. Tennstedt, 1993, Contact Dermatitis.

POTENTIATION OF CUTANEOUS REACTIVITY AND BLOOD LEUCOCYTE HISTAMINE RELEASE BY DEUTERIUM OXIDE IN HUMAN BEINGS

J. Charpin, D. Vervloet, P. Vellieux, 1976, Acta allergologica.

17q21 variants modify the association between early respiratory infections and asthma

F Kauffmann, J Bousquet, P Scheinmann, 2009, European Respiratory Journal.

Adverse reactions to drugs

D. Vervloet, Daniel Vervloet, Stephen Durham, 1998, BMJ.

Clustering patterns of LOD scores for asthma-related phenotypes revealed by a genome-wide screen in 295 French EGEA families.

J. Bousquet, I. Annesi-Maesano, M. Lathrop, 2004, Human molecular genetics.

Genome screen for asthma and related phenotypes in the French EGEA study.

J. Bousquet, I. Annesi-Maesano, M. Lathrop, 2000, American journal of respiratory and critical care medicine.

Anaphylactic reaction to rifamycin SV: presence of specific IgE antibodies.

L. Venemalm, A. Magnan, D. Vervloet, 1999, The Journal of allergy and clinical immunology.

Genome screen in the French EGEA study: detection of linked regions shared or not shared by allergic rhinitis and asthma

J. Bousquet, I. Annesi-Maesano, M. Lathrop, 2005, Genes and Immunity.

[Bronchial obstruction by an aberrant left pulmonary artery misdiagnosed as asthma in a 7 year old child].

S. Boniface, A. Magnan, D. Vervloet, 2004, Revue des maladies respiratoires.

Altered compartimentalization of transforming growth factor‐β in asthmatic airways

F. Retornaz, A. Magnan, A. Tsicopoulos, 1997 .

Altered compartmentalization of transforming growth factor-beta in asthmatic airways.

F. Retornaz, A. Magnan, A. Tsicopoulos, 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Seasonal increase of carbachol airway responsiveness in patients allergic to grass pollen. Reversal by corticosteroids.

M. Badier, D. Vervloet, J. Orehek, 1984, The American review of respiratory disease.

183 Role of the quaternary ammonium ions in the mechanisms of anaphylactic reactions to succinylcholine (Sch)

P. Bongrand, M. Senft, D. Vervloet, 1985 .

Bronchial Hyperresponsiveness to Methacholine Is Associated With Increased Common Carotid Intima-Media Thickness in Men

P. Ducimetiere, M. Zureik, B. Leynaert, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Do patients with skin allergies have higher levels of anxiety than patients with allergic respiratory diseases? Results of a large‐scale cross‐sectional study in a French population

I. Annesi-Maesano, P. Mathelier-Fusade, D. Vervloet, 2006, The British journal of dermatology.

Epidemiology of allergic drug reactions.

M. Zoppi, D. Vervloet, R. Hoigne, 1993, Monographs in allergy.

from the French PAARC survey Twenty five year mortality and air pollution: results

I. Annesi-Maesano, L. Filleul, V. Rondeau, 2006 .

Monitoring a lab-scale fluidized bed dryer: A comparison between pressure transducers, passive acoustic emissions and vibration measurements

John Nijenhuis, J. R. van Ommen, J. Nijenhuis, 2010 .

[Yellow fever: desensitization to an anti-amaril 17 D vaccine performed on a patient with anaphylaxis to eggs].

J. Charpin, D. Vervloet, J. Birnbaum, 1987, Bulletin de l'Académie Nationale de Médecine.

Is intrinsic asthma a hereditary disease?

J. Charpin, D. Charpin, D. Vervloet, 1991, Allergy.

Air pollution and asthma control in the Epidemiological study on the Genetics and Environment of Asthma

J. Bousquet, B. Jacquemin, N. Künzli, 2011, Journal of Epidemiology & Community Health.

Rhinitis alone or rhinitis plus asthma: what makes the difference?

A Magnan, A. Magnan, M. Badier, 1998, The European respiratory journal.

238 Acetyl-salicylic acid therapy in aspirinsensitive asthmatics

J. Charpin, D. Vervloet, G. Baldocchi, 1983 .

Prevalence of allergy to hymenoptera stings in different samples of the general population.

D. Charpin, D. Vervloet, J. Birnbaum, 1992, The Journal of allergy and clinical immunology.

Variable content of Fel d 1 variants in house dust and cat extracts may have an impact on allergen measurement.

R. Lebrun, D. Vervloet, C. Ronin, 2012, Journal of investigational allergology & clinical immunology.

Distribution of Core Fragments from the Major Cat Allergen Fel d 1 Is Maintained among the Main Anatomical Sites of Production

R. Lebrun, D. Vervloet, C. Ronin, 2010, International Archives of Allergy and Immunology.

134 Rapid 3H30 venom desensitization (DES) in patients (pts) with anaphylactic sensitivity to hymenoptera (HYM)

D. Charpin, D. Vervloet, A. Arnaud, 1988 .

Prevalence of asthma and rhinitis in relation to long‐term exposure to gaseous air pollutants

D. Vervloet, D. Vervloet, M. Ramadour, 2000, Allergy.

Intensification of co-current gas–liquid reactors using structured catalytic packings: A multiscale approach

J. Nijenhuis, F. Kapteijn, J. R. Ommen, 2009 .

Medical Indoor Environment Counselor (MIEC): role in compliance with advice on mite allergen avoidance and on mite allergen exposure

G. Hédelin, P. Godard, F. de Blay, 2003, Allergy.

Venom immunotherapy induces monocyte activation

A Magnan, P Bongrand, P. Bongrand, 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Asthma control assessed in the EGEA epidemiological survey and health-related quality of life.

J. Bousquet, V. Siroux, I. Pin, 2012, Respiratory medicine.

Origine des allergènes du chat

D. Vervloet, D. Charpin, J. Birnbaum, 1993 .

Costs of managing asthma as defined by a derived Asthma Control TestTM score in seven European countries

T. Clark, D. Vervloet, A. Williams, 2006, European Respiratory Review.

[Provocation tests to local anesthetics].

J. Charpin, D. Vervloet, A. Arnaud, 1984, Presse medicale.

Medication requirements and house dust mite exposure in mite‐sensitive asthmatics

D. Charpin, D. Vervloet, J. Birnbaum, 1991, Allergy.

[Allergies: determinants of T2 lymphocyte polarization and desensitization mechanisms].

A. Magnan, D. Vervloet, 1997, Revue des maladies respiratoires.

[The epidemiology of allergy to house dust mites].

D. Charpin, D. Vervloet, F. Porri, 1991, Revue des maladies respiratoires.

Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. A double-blind, placebo-controlled study.

D. Vervloet, C. André, J. Birnbaum, 2007, International archives of allergy and immunology.

Effects of castration and testosterone on Fel d I production by sebaceous glands of male cats: II—morphometric assessment

D. Charpin, D. Vervloet, C. Charpin, 1994 .

[Does asthma represent a risk factor for anaphylaxis?].

D. Vervloet, F. Rancé, O. Clément, 2007, Revue des maladies respiratoires.

Concurrent allergic diseases: a cross‐sectional study in a French population

I. Annesi-Maesano, P. Mathelier-Fusade, D. Vervloet, 2006, Allergy.

Bronchial challenge to house dust can induce immediate bronchoconstriction in allergic asthmatic patients.

M. Thibaudon, D. Charpin, L. M'Raihi, 1990, Annals of allergy.

Air Pollution and Asthma Control in the Epidemiological Study on Genetics and Environment of Asthma (EGEA)

J. Bousquet, B. Jacquemin, N. Künzli, 2009 .

Classification 2002 des pneumopathies interstitielles idiopathiques

B. Chetaille, F. Retornaz, M. Reynaud‐Gaubert, 2004 .

Reported incidence of occupational asthma in France, 1996–99: the ONAP programme

M. Kopferschmitt‐Kubler, G. Pauli, D. Vervloet, 2003, Occupational and environmental medicine.

Standardization of house‐dust sampling

D. Charpin, D. Vervloet, J. Birnbaum, 1992, Allergy. European Journal of Allergy and Clinical Immunology.

Pollen exposure and sensitization

D. Charpin, D. Vervloet, B. Balansard, 1998, Allergy.

Adherence: the goal to control asthma.

L. Boulet, J. Foster, D. Vervloet, 2012, Clinics in chest medicine.

Assessment of the severity of asthma by an expert system. Description and evaluation.

B Wallaert, J Marsac, C. Brambilla, 1995, American journal of respiratory and critical care medicine.

[Role of eosinophilia in atopic pathology].

A. Magnan, D. Vervloet, 1998, Medecine tropicale : revue du Corps de sante colonial.

[Anaphylactic type of accidents due to myorelaxing agents during general anesthesia. Clinical and biological study].

J. Charpin, D. Vervloet, A. Arnaud, 1977, La Nouvelle presse medicale.

Insights into severe asthma control as assessed by guidelines, pulmonologist, patient, and partner

D. Vervloet, M. Molimard, V. Le Gros, 2010, Journal of Asthma.

Treatment of acute asthma: Effect of intravenous corticosteroids andβ2-adrenergic agonists

J. Charpin, D. Vervloet, A. Arnaud, 2007, Lung.